Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 30;13(5):749-759.
doi: 10.21037/gs-23-363. Epub 2024 May 16.

Oncoplastic surgery in the USA: a review of where we started, where we are today and where we are headed

Affiliations
Review

Oncoplastic surgery in the USA: a review of where we started, where we are today and where we are headed

Lauren M Willcox et al. Gland Surg. .

Abstract

The surgical management of breast cancer has evolved tremendously over the last century and now includes oncoplastic techniques that improve both cosmetic and oncologic outcomes for patients. The purpose of this review is to provide the reader with a broad overview of the history of oncoplastic breast surgery in the United States (USA), and to summarize important patient factors and technical innovations for optimal operative planning in the era of multimodal treatment of breast cancer. The indications for oncoplastic surgery (OPS) have broadened significantly as more women pursue breast conservation with preservation of their native breast tissue. The operative philosophy of OPS is based on fundamental reconstructive principles, with technique selection based largely on tumor size and location. Reduction mammoplasty and mastopexy techniques have become some of the most utilized procedures in OPS due to their versatility to address tumors in almost all areas of the breast. Volume replacement techniques with locoregional perforator flaps continue to gain popularity as a single-stage reconstructive option for women with large tumor to breast ratios, especially with specialized plastic surgeons at high volume, academic centers. The oncologic advantages of OPS have allowed women to avoid mastectomy with improved margin control, re-excision rates, and equivalent overall survival all while preserving the aesthetic outcomes for these patients. Despite the proven benefits of OPS, numerous healthcare systems barriers including insurance status, geographic location, referral patterns, and racial disparities all continue to play a role in access to surgical sub-specialized breast oncology care demonstrating the need for ongoing research and education about oncoplastic principles.

Keywords: Oncoplastic breast surgery; breast cancer reconstruction; oncoplastic breast reduction; oncoplastic surgery (OPS).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-23-363/coif). The series “Hot Topics in Breast Reconstruction World Wide” was commissioned by the editorial office without any funding or sponsorship. A.L. is a consultant for RTI surgical. The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
Superomedial pedicle oncoplastic reduction. (A) Preoperative photograph with location of the area to be excised (blue circle). (B) Preoperative markings with location of the area to be excised (blue circle). (C) Intraoperative immediate result after superomedial pedicle. (D) Postoperative result 3 months after surgery and 1 month after radiation.
Figure 2
Figure 2
Inferior pedicle oncoplastic reduction. (A) Preoperative photograph with location of the area to be excised (blue circle). (B) Preoperative markings with location of the area to be excised (blue circle). (C) Intraoperative dissection of the Inferior pedicle. (D) Postoperative result 3 months after surgery and 1 month after radiation.

References

    1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41. 10.1056/NEJMoa022152 - DOI - PubMed
    1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32. 10.1056/NEJMoa020989 - DOI - PubMed
    1. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000;92:1143-50. 10.1093/jnci/92.14.1143 - DOI - PubMed
    1. Kimball CC, Nichols CI, Vose JG, et al. Trends in Lumpectomy and Oncoplastic Breast-Conserving Surgery in the US, 2011-2016. Ann Surg Oncol 2018;25:3867-73. 10.1245/s10434-018-6760-7 - DOI - PubMed
    1. Urban C, Lima R, Schunemann E, et al. Oncoplastic principles in breast conserving surgery. Breast 2011;20 Suppl 3:S92-5. 10.1016/S0960-9776(11)70302-2 - DOI - PubMed